source
- Sarepta Therapeutics agrees to pay $39 million to settle gene therapy dispute with RegenxbioSarepta Therapeutics has agreed to resolve a dispute with Regenxbio by paying $39 million. The payment settles claims related to gene therapy technology that both companies have been developing.…
- Heidi Overton, Trump’s FDA commissioner nominee, to face Senate confirmation hearingHeidi Overton has been nominated by President Donald Trump to serve as the next commissioner of the U.S. Food and Drug Administration. She is scheduled to appear before the Senate Health, Educatio…